Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2014
June 2014, Vol 4, No 4
June 2014, Vol 4, No 4
Imbruvica (Ibrutinib) the First Bruton’s Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia
By
Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›
Imbruvica YOU&i Access Program and Support for Patients
Read More ›
Providing Social Support to Patients with Cancer
Practice Management
Read More ›
ICD-9 or ICD-10: What Is the Point?
By
Karna W. Morrow, CPC, RCC, CCS-P, PCS
Coding and Billing
,
Reimbursement
Regardless of which version you are considering, the International Classification of Diseases, Clinical Modification (ICD-CM) is a morbidity classification published by the United States for classifying diagnoses and reasons for visits in all healthcare settings.
Read More ›
Shopping for High-Quality, Affordable Oncology Care
By
Carla Balch, CEO
Quality Care
Read More ›
Drug Compounding: New Rule a Game Changer for Oncology Practices
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
Fair Labor Standards Act: Exemptions Review
By
Robert D. Orzechowski, MBA, SPHR, SHRM-SCP
Read More ›
Do’s and Don’ts in Physician-Hospital Alignment, Part 1
By
Max Reiboldt, CPA
Practice Management
Read More ›
FDA-Approved Medications Used for the Treatment of Lung Cancer
ICD Codes
Read More ›
New Clinical Trials Under Way
Clinical Trials Tracker
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
2023 Spotlight: Amgen
3.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes